Par Drugs And Chemicals
PAR · Chemicals > Chemicals · Chairman: Falgun Vallabhbhai Savani · MD: Falgun Vallabhbhai Savani · Listing date: May 16, 2019 · Employees: 92 · Bhavnagar · http://pardrugs.com

Stock Price vs Company Growth
1d
2.7%
1w
3.8%
1m
26.7%
3m
18.9%
6m
15.0%
1y
23.6%
5y
66.3%
all
56.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 281 2.7%
218
320
Company Overview

Sales
104 Cr
Growth: 1.2%
Profit after Tax
18.3 Cr
Growth: 25.4%
Micro Cap
346 Cr
P/E: 18.9x
Industry P/E: 31.7x
Fundamentals

Sales (Cr) ₹ 104
Growth 1.2%
EBITDA 25.9%
P/S 3.3x
Dividend 0.0%
P/E 18.9x
Book Value ₹ 78.6
PEG Ratio 16.4x
ROE 20.7%
P/B 3.6x
Shareholding Pattern

Institutions
Sunita Ben Paragbhai Shah
1.92 %
Parag Jayantibhai Shah
1.14 %
Promoters
Jignesh Vallabhbhai Savani
21.78 %
Falgun Vallabhbhai Savani
21.5 %
Vallabhbhai J Savani
19.46 %
Ghanshayambhai B Savani
6.41 %
Saritaben Vallabhbhai Savani
1.8 %
Others
Increase    Decrease    No change
Company Profile Detailed

:PDCL is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. It currently produce various range of Antacid Molecules which are available in the market and are in great demand.Key Events and Milestones:1999: Incorporated as a Private Limited Company with the name ‘Par Drugs and Chemicals Private Limited’.1999: Acquisition of the ongoing business of the M/s. Par In Organic.
Investors (5)